Selection in the literature
The electronic search identified 2,343 potentially relevant studies. After reading the title and abstract, we excluded 2,238 publications for the following reasons: duplicate articles, study design, sample did not include DM2 or older adults, did not assess falls. Based on reading the abstract, 30 studies were left. Of this total, 18 were excluded for not presenting data on the ages of the younger and older adults separately; three articles were excluded for not presenting outcome measures such as OR, HR, and RR; one article was excluded for being a review; and one article was excluded for comparing only physical performance. No attempt was made to access unpublished studies or other ‘grey’ literature. After we applied the inclusion and exclusion criteria, 12 publications and 8 studies were included for meta-analysis (See “Figure 1” in the text below.
Modified from: Moher et al. The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed 1000097.
Study characteristics
The 12 included studies were published from 2002 to 2019 and conducted in eight different countries. The designs adopted in these studies were as follows: cohort20,25−27; prospective cohort28–31; cross-sectional19,32; retrospective cross-sectional33; prospective cross-sectional34.
The sample size ranged from 77 to 22,200. A total of 40,778 participants were identified and analysed in the present review. The duration of follow-up was from 3 months to 10 years. The age of the participants ranged from 60 to 101 years. The sample of ten studies included older men and women, and two studies included only older women in their sample28,29. The general characteristics of the included studies are listed in Table 1 (See file “Table_1”). Additional information about the characteristics of the cohort and cross-sectional of included studies were presented in Additional files for Review (“Additional_file_2_Table_S2” and “Additional_file_3_Table_S3” respectively).
Table 1
Baseline characteristics of the included studies
Study/year | Region | Design | Population | Subject (%women) | Age/ Range of mean | Ascertainment of falls | Falls number (%) | Follow-up duration | Punctuation NOS | DM diagnosis (DM number) |
Schwartz et al. (2002)(32) | USA | Prospective cohort study | Community | 9.249 (100% women) | 73.5 ± 5.0 | Postcard / phone | 1,640 (18%) | 2 years | 7 | Self-reports (629) |
Maurer et al (2005)(30) | USA | Prospective cohort study | Long-stay institution | 139 (84% women) | 88 ± 7 | Berg balance scale | 49 | Range 97-8854 days | 8 | Prescription of oral hypoglycemic agent or insulin therapy (extracted from medical records) (18) |
Volpato et al (2005) (29) | USA | Cohort | Community | 1.002 (100% women) | 75.3 ± 6.5 | Questionnaire | 26,5 | 3 years | 8 | Specific disease investigation algorithm developed for this study (136) |
Tilling et al. (2006) (36) | UK | Cross-sectional prospective | Hospital | 77 (58.5% women) | 73 | Questionnaire | 39% | 5 months | 5 | Self-reports (77) |
Schwartz et al. (2008) (28) | USA | Cohort | Community | 3.075 (44.6% women) | 73.6 ± 2.7 | Questionnaire / self-reports | 23% | 5 years | 8 | Self-report, use of hypoglycemic medication or an elevated fasting glucose level (≥ 126 mg/dl) or 2-hour oral glucose tolerance test (≥ 200 mg/dl) (719) |
Pijpers et al. (2011)(20) | NL | Cohort | Community | 1.145 (49.8% women) | 75.4 ± 6.5 | Calendar | 232 (20,3%) | 3 years | 8 | Self-report and use of glucose-lowering medication (85) |
Roman de Mettilinge et al (2013)(31) | BE | Prospective cohort | Community | 199 (68.3% women) | 76.9 ± 9.4 | Questionnaire | 56 (28,4%) | 12 months | 6 | General practitioner or specialist physician confirmed the presence or absence of DM (104) |
Yau et al (2013) (33) | USA | Prospective cohort | Community | 3.075 (52% women) | 73.7 ± 2.8 | Medical record | 293 | 10 years | 7 | Self-reported medical diagnosis, self-reported use of antidiabetic medications, elevated fasting glucose level (≥ 126 mg/dL) or elevated levels on a 2-hour oral glucose tolerance test (≥ 200 mg/dL) (719) |
Bruce et al. (2015)(19) | AU | Cross-sectional | Community | 186 (50% women) | 70.3 ± 10.1 | Questionnaire | 39 (20,9%) | -* | 4 | Self-report and fasting glucose levels (186) |
Chiba et al. (2015)(35) | JP | Cross-sectional retrospective | Community | 211 (70,88% women) | 76.2 ± 6.8 | Questionnaire | 62 | Every 3 months for 3 years | 5 | Self-reports (168) |
Randolph et al (2019)(27) | USA | Cohort | Community | 22.200 (63.3% women) | 78.3 ± 6.9 | Medical record | 411 | 5 years | 6 | Medical record (11.000) |
Rashedi et al (2019)(34) | IR | Cross-sectional | Community | 220 (58% women) | 69.82 ± 9.9 | Questionnaire | 77 (38,5%) | -* | 3 | Medical record (220) |
Source: Research data, 2022. -*, Did not provide data on the duration of follow-up; DM, Diabetes Mellitus; NOS, NewCastle Ottawa. |
As can be seen in Table 1, a population older adult was studied in 10 research reports. Two other studies included older adults from other settings: the hospital setting and the long-term care facility setting. Furthermore, the number of subjects varied widely (from 77 to 22,200), as did the methods of defining a diagnosis of DM, ranging from studies using self-reports only27,30,33; combining self-reports and laboratory tests19,20,26,28,31; medical records25,32; confirmation by a physician29 or using an algorithm27.
The classic definition of the outcome fall, which is well established in the literature14 was adopted in 3 studies20,29,33. Schwartz et al.30 added to this definition “falling and hitting an object such as a table or a ladder”.
Methodological quality of included studies
A low risk of bias was present in 11 studies and only in the study by Rashedi et al.32 was there a higher risk of bias. In addition, the complete evaluation of the studies in the Newcastle-Ottawa (NOS) was described in Table 2- Quality Assessment and Risk of Bias of included studies. (See file “Table_2”).
Table 2 - Quality Assessment and Risk of Bias of included studies.
Cross-sectional studies
|
Author
|
Year
|
|
Selection
|
|
Comparability
|
Outcome
|
|
Score
|
Quality
|
|
|
Representativeness
|
Selection
|
Ascertainment
|
Adjustment for confounders
|
Assessment
|
Response rate
|
|
|
Bruce
|
2015
|
*
|
*
|
*
|
*
|
-
|
-
|
4
|
High
|
Chiba
|
2015
|
*
|
*
|
*
|
*
|
*
|
-
|
5
|
High
|
Rashedi
|
2019
|
*
|
-
|
*
|
*
|
-
|
-
|
3
|
Low
|
Tilling
|
2005
|
*
|
*
|
-
|
*
|
*
|
*
|
5
|
High
|
Source: Research data, 2022.
Cohort studies
|
|
|
|
|
|
Author
|
Year
|
|
|
Selection
|
|
Comparability
|
|
Outcome
|
|
Score
|
Quality
|
|
|
Representativeness
|
Selection
|
Ascertainment
|
Outcome
|
Adjustment for confounders
|
Assessment
|
Duration
|
Completeness of follow-up
|
|
|
Maurer
|
2005
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
8
|
High
|
Pijpers
|
2011
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
8
|
High
|
Randolph
|
2019
|
*
|
*
|
-
|
-
|
*
|
*
|
*
|
*
|
6
|
High
|
Roman de Mettilinge
|
2013
|
*
|
*
|
*
|
*
|
*
|
-
|
*
|
-
|
6
|
High
|
Schwartz
|
2002
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
-
|
7
|
High
|
Schwartz
|
2008
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
8
|
High
|
Volpato
|
2005
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
8
|
High
|
Yau
|
2013
|
*
|
*
|
*
|
*
|
*
|
*
|
*
|
-
|
7
|
High
|
Source: Research data, 2022.
Falls Outcome Assessment Method
The preferred method of falls outcome assessment used in the studies was the questionnaire, which was used in 7 studies19,26,27,29,32,33,34. One study used the Berg Balance Scale28, another study used a postcard30, two other studies used medical records25,31 and finally one used a calendar 20.
Risk factors associated with falls
Twelve studies involving 14,061 diabetics reported 1,394 falls in diabetic older adults. The HR values, OR and p-value for the risk factors for falls and the adjustments for covariates of the cohort and cross-sectional studies are shown in Table S2 and S3 (“Additional_file_2_Table_S2” and “Additional_file_3_Table_S3” respectively).
For the cohort studies20,25−31, participants with DM had a higher incidence rate of falling, recurrent falls, use of TCA / GABA-analog, insulin use, and being female. In these studies, the risk factors for falls were insulin use, followed by DM and medications (Table S2).
The risk factors for falls in the older adults in cross-sectional studies varied widely among the different studies: fear of falling, age, medication use, hypoglycemia, gait problems, body balance difficulty, hypotension, and elderly women (Table S3).
Multiple falls were reported in two studies29,33, with Chiba et al. showing that hypoglycemia and the Fall Risk Index were significant for multiple falls in diabetic patients. Recurrent falls were more prevalent in individuals with DM20 and women on insulin therapy27,30.
Investigation of peripheral neuropathy as a risk factor for falls was reported in a single study, where recurrent falls and loss of pressure sensitivity were independently associated with the risk of falling more than once a year and accounted for 3–6% of the relationship between diabetes and falling30. Visual impairment caused by DM is another complication of DM frequently reported as a risk factor for the older adults in the general population. However, we did not find studies investigating visual impairment and/or the presence of retinopathy as risk factors for falls in older adults with DM.
High glycated hemoglobin (HbA1C > 7%) was associated with a risk factor for falls and dependence on a walking aid, such as a cane34.
Association between diabetes mellitus and risk of falls: results of meta-analysis
As observed in Figs. 3 and 4, there were significant differences among the analyzed studies. See “Figure_2”, “Figure_3”, and, “Figure_4”.
In Fig. 2, the risk of those exposed with diabetes developing the outcome falls is 63% in relation to non-diabetic (HR 1.63; 95% CI [1.30–2.05]). The heterogeneity of this analysis was considerable (I2 = 71.5%). While the chance of falls in older adults with diabetes is 49% compared to non-diabetic older adults (OR 1.49; 95% CI [1.29–1.72]) with the heterogeneity (I² = 36.4%) moderate, as shown in Fig. 3).
The chance of falls in older adults with diabetes who take insulin is 162% (OR 2.62; 95% CI [1.87–3.65]) with heterogeneity in Fig. 4) (I² = 0.0%; low). No results were found in studies related to diabetic polyneuropathy.